Paid Clinical Trials in Chandler, AZ
As of August 2026, 126 paid clinical trials are recruiting in Chandler, Arizona. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Chandler offers studies at sites including Ironwood Cancer & Research Centers for conditions such as Obesity, Overweight, Non-Small Cell Lung Cancer, Asthma. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Chandler
Trials by drug in Chandler
Filter results
Newly added in Chandler
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
A Phase 2 Study to Evaluate the Pharmacodynamics, Safety and Tolerability of BGE-102 in Participants With Obesity and Cardiovascular Risk Factors
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
118 clinical trials
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)
Efficacy and Safety of Oral KAI-7535 in Adult Participants Living With Obesity or Overweight With at Least 1 Weight-Related Comorbidity
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
Study of DONQ52 in Active Celiac Disease
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Top Research Study Locations in Chandler
Researchers run research studies in Chandler, AZ at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Ironwood Cancer & Research Centers | Advanced Melanoma, Advanced Non-Small Cell Lung Cancer, Bladder Carcinoma | 13 |
| Chandler Clinical Trials | Alzheimer's Disease Psychosis, Asthma, Celiac Disease | 8 |
| Arizona Clinical Trials | Healthy Volunteers, Hepatic Impairment, Localized Prostate Cancer | 7 |
| Arizona Liver Health | Metabolic Dysfunction-Associated Steatotic Liver Disease, Ascites Hepatic, Cirrhosis, Liver | 7 |
| Chandler Regional Medical Center | Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities, Glioblastoma, Hemorrhage | 4 |
| AZ Gastro Care | Colitis, Ulcerative, Crohn Disease, Crohn's Disease | 3 |
| GSK Investigational Site | Non-alcoholic Fatty Liver Disease, Liver Diseases, Alcoholic, Metabolic Dysfunction-Associated Steatohepatitis | 3 |
| Ironwood Cancer and Research Centers | Colorectal Cancer, Breast Cancer, CRC | 3 |
| New Horizons Clinical Trials | Contraception, Endometriosis, Ovarian Neoplasms | 3 |
| Ironwood Cancer and Research Center | Colorectal Neoplasms, Squamous Cell Carcinoma of Head and Neck, Non-Small Cell Lung Cancer | 3 |
| Chandler Clinical Research Trials | Bipolar I Disorder, Bipolar II Disorder, Chronic Obstructive Pulmonary Disease | 3 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 2 |
| Akero Clinical Study Site | MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASH With Fibrosis, NASH - Nonalcoholic Steatohepatitis | 2 |
| Arizona Clinical Trials - Chandler | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension | 2 |
| Arizona Eye Center | AMD, Dry Eye Disease (DED) | 2 |
| Arizona Liver Health - Chandler | Chronic Idiopathic Constipation (CIC), MASH - Metabolic Dysfunction-Associated Steatohepatitis | 2 |
| Dignity Health Chandler Regional Medical Center | Hypovolemia, Open tíbia Fracture, Sepsis | 2 |
| Ironwood Cancer and Research Centers Chandler Ii | Gastroesophageal Junction Adenocarcinoma, HR+/HER2- Breast Cancer, Metastatic Gastric Adenocarcinoma | 2 |
| The Institute for Liver Health II dba Arizona Clinical Trials - Mesa | Obesity, Overweight | 2 |
| TrialSphere | Acute Migraine, Migraine | 2 |
| TrialSphere Corp, Merz Investigational | Chronic Migraine, Episodic Migraine | 2 |
| AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Chandler | Overweight or Obesity, Psoriatic Arthritis, Radiographic Axial Spondyloarthritis | 2 |
| AARR- Chandler AZ | Psoriatic Arthritis | 1 |
| ACCOMPLISH-2 Research Site | Chronic Weight Management, Obesity, Overweight | 1 |
| AZ Gastro Care - Chandler | Ulcerative Colitis, Ulcerative Colitis Chronic | 1 |
Active & Upcoming Studies in Chandler (2026)
Recruiting trials in Chandler grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (26 active studies)
Diabetes & metabolic (20 active studies)
- A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2) · Phase 3 · Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- A Study to Assess the Efficacy, Safety and Tolerability of AT673 Co-administered With Semaglutide in Adult Participants With Type 2 Diabetes (T2D) and Overweight or Obesity · Phase 2 · Antag Therapeutics
Neurology & pain (6 active studies)
- A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
- A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
Cardiovascular (6 active studies)
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease · Phase 3 · Alnylam Pharmaceuticals
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease · Phase 3 · Boehringer Ingelheim
HIV / STI (2 active studies)
- A Study Evaluating the Efficacy and Safety of ALG-000184 Compared With Tenofovir Disoproxil Fumarate in Untreated HBeAg-Positive and HBeAg- Negative Adult Subjects With Chronic Hepatitis B (B-SUPREME) · Phase 2 · Aligos Therapeutics
- A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection · Phase 1 · GigaGen, Inc.
Mental health & behavior (2 active studies)
- 52-week Open Label Safety-Tolerability Study · Phase 3 · LB Pharmaceuticals Inc.
- A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder · Phase 2 · AbbVie
Eye & vision (2 active studies)
- An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye Disease · Phase 2 · Dompé Farmaceutici S.p.A
- A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy · Phase 3 · Regeneron Pharmaceuticals
Vaccines (1 active study)
- Playing Game to Learn About Children's Vaccine Project · Michigan State University
Common conditions studied in Chandler
- Obesity (5 active studies)
- Overweight (5 active studies)
- Non-Small Cell Lung Cancer (4 active studies)
- Asthma (3 active studies)
- Metabolic Dysfunction-Associated Steatotic Liver Disease (3 active studies)
- Breast Cancer (2 active studies)
Leading research sponsors in Chandler
- Pfizer
- Eli Lilly and Company
- AstraZeneca
- Janssen Research & Development, LLC
- Merck Sharp & Dohme LLC
Frequently asked questions
How many paid clinical trials are currently recruiting in Chandler?
There are approximately 126 recruiting clinical trials in Chandler, Arizona listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Chandler pay participants?
Most recruiting trials in Chandler compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Chandler?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Chandler?
The most common conditions under active study in Chandler include Obesity (5), Overweight (5), Non-Small Cell Lung Cancer (4), Asthma (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Chandler?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Chandler on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Chandler?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Chandler?
Recruiting research sites in Chandler include Ironwood Cancer & Research Centers, Chandler Clinical Trials, Arizona Clinical Trials, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Chandler right now?
The largest active categories in Chandler are Cancer & tumors (26), Diabetes & metabolic (20), Neurology & pain (6). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.